According to our new research study on "Skull Clamp Market Forecast to 2031 - Global Analysis - by product, application, material, and end user," the market is expected to grow from US$ 2.09 billion in 2023 to US$ 4.33 billion by 2031; it is anticipated to record a CAGR of 9.6% from 2023 to 2031. The increasing number of brain and spinal surgeries and the rising number of traumatic brain injury cases drive the market growth. However, the growing number of injuries caused by skull clamps hampers the market growth. The surgical robot innovation and adoption are expected to bring new skull clamp market trends in the coming years.
Skull clamps are simple pieces of surgical equipment designed to prevent unintended movement of the patient’s head during neurosurgical and spine procedures. The skull clamp must be applied along the centerline of the patient’s head with pins entering the skull perpendicularly. Failure to properly position the skull clamp on the patient’s head could result in patient injury such as scalp laceration due to skull pin slippage. Skull clamps are frequently used in cranial neurosurgical procedures and selected cervical procedures. Its demand is majorly driven by the growing number of neurosurgeries owing to the rising incidence of brain and spinal tumors, brain aneurysms or cerebral aneurysms, and Parkinson’s disease.
North America accounted for a major share of the global skull clamp market in 2023. The blood collection tube for liquid biopsy market in North America is segmented into the US, Canada, and Mexico. The US dominated the North America skull clamp market due to rising awareness among the population, the surge in research and development activities, and favorable government policies. Moreover, the market growth in Canada is expected to grow due to increasing support from the government to address the rising concerns about brain disorders. The market across Mexico is also estimated to grow due to a rise in medical industrialization and exports of medical devices to the US and other countries. The US holds a significant share of the skull clamp market in North America.
Traumatic brain injury (TBI) is considered to be a leading cause of death and disability among the majority of the population in the US. The CDC stated that 69,473 TBI-related deaths occurred in 2021, while ~214,110 TBI-related hospitalizations were recorded in 2020. This translates to over 586 hospital admissions and 190 TBI-related fatalities every day. TBI-related hospitalizations and death rates were higher among people aged 75 and above. This age group is responsible for approximately 32% of TBI-related hospitalizations and 28% of TBI-related deaths. As per the Centers for Disease Control and Prevention (CDC), the cost of treatment of traumatic brain injuries in the US is ~US$ 45 billion each year. Moreover, an estimated 80,000-90,000 patients in the US suffer from disabilities due to traumatic brain injuries every year. Also, the penetration of skull clamps across several end user applications is expected to increase product developments, which is likely to fuel the skull clamp market in the US by 2030. The surge in the geriatric population, as well as the subsequent increase in incidences of brain aneurysms, fuels the growth of the skull clamp market in Canada.
TBI affects 2% of the population of Canada, and there are 18,000 hospitalizations for TBI each year. It is prevalent in women between the ages of 15 and 24. Moreover, as per the Brain Aneurysm Foundation, ~8-10 individuals per 100,000 people, or approximately 2,800-3,500 citizens of Canada, suffer a burst aneurysm each year, which accounts for approximately 3% of all hemorrhagic strokes. It has also been demonstrated that in most cases, aneurysms develop after age 40, and ruptures occur most commonly after age 50. According to the Canada Institute of Health Information, the population aged 65 years and above is expected to increase by 68% in the next 20 years.
As per the same source, in 2023, more than 10 million people across the world were suffering from Parkinson’s disease. According to Alzheimer's Association, about 6.9 million people aged 65 years and above in America are expected to suffer from Alzheimer’s in 2024. Drugs are generally used for the treatment of these diseases. However, there is an increase in focus on the use of surgical methods such as deep brain stimulation for the treatment of neurological disorders, specifically when the drugs have low effects. According to an article "Epilepsy Surgery", epilepsy patients may be treated with the help of a small electrode.
As per the same article, about 50% of patients who undergo neuromodulation surgeries may experience better control of their seizures. Between 50% and 85% of individuals who undergo resection surgery or a hemispherectomy may experience significant improvement in seizure control and become seizure-free in some cases. Due to the better results of surgical procedures for neurological disorders, there will be an increase in the number of patients that will opt for these options, which, in turn, will fuel the number of neurological surgeries. As these surgeries are related to the brain, stabilization of the skull during the surgery is important. Thus, there will be an increase in demand for skull clamps. Thus, the increasing prevalence of neurological disorders is expected to offer lucrative opportunities for the growth of the skull clamp market during the forecast period.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), North American Spine Society are among the primary and secondary sources referred to while preparing the skull clamp market report.
Skull clamps are simple pieces of surgical equipment designed to prevent unintended movement of the patient’s head during neurosurgical and spine procedures. The skull clamp must be applied along the centerline of the patient’s head with pins entering the skull perpendicularly. Failure to properly position the skull clamp on the patient’s head could result in patient injury such as scalp laceration due to skull pin slippage. Skull clamps are frequently used in cranial neurosurgical procedures and selected cervical procedures. Its demand is majorly driven by the growing number of neurosurgeries owing to the rising incidence of brain and spinal tumors, brain aneurysms or cerebral aneurysms, and Parkinson’s disease.
North America accounted for a major share of the global skull clamp market in 2023. The blood collection tube for liquid biopsy market in North America is segmented into the US, Canada, and Mexico. The US dominated the North America skull clamp market due to rising awareness among the population, the surge in research and development activities, and favorable government policies. Moreover, the market growth in Canada is expected to grow due to increasing support from the government to address the rising concerns about brain disorders. The market across Mexico is also estimated to grow due to a rise in medical industrialization and exports of medical devices to the US and other countries. The US holds a significant share of the skull clamp market in North America.
Traumatic brain injury (TBI) is considered to be a leading cause of death and disability among the majority of the population in the US. The CDC stated that 69,473 TBI-related deaths occurred in 2021, while ~214,110 TBI-related hospitalizations were recorded in 2020. This translates to over 586 hospital admissions and 190 TBI-related fatalities every day. TBI-related hospitalizations and death rates were higher among people aged 75 and above. This age group is responsible for approximately 32% of TBI-related hospitalizations and 28% of TBI-related deaths. As per the Centers for Disease Control and Prevention (CDC), the cost of treatment of traumatic brain injuries in the US is ~US$ 45 billion each year. Moreover, an estimated 80,000-90,000 patients in the US suffer from disabilities due to traumatic brain injuries every year. Also, the penetration of skull clamps across several end user applications is expected to increase product developments, which is likely to fuel the skull clamp market in the US by 2030. The surge in the geriatric population, as well as the subsequent increase in incidences of brain aneurysms, fuels the growth of the skull clamp market in Canada.
TBI affects 2% of the population of Canada, and there are 18,000 hospitalizations for TBI each year. It is prevalent in women between the ages of 15 and 24. Moreover, as per the Brain Aneurysm Foundation, ~8-10 individuals per 100,000 people, or approximately 2,800-3,500 citizens of Canada, suffer a burst aneurysm each year, which accounts for approximately 3% of all hemorrhagic strokes. It has also been demonstrated that in most cases, aneurysms develop after age 40, and ruptures occur most commonly after age 50. According to the Canada Institute of Health Information, the population aged 65 years and above is expected to increase by 68% in the next 20 years.
Increasing Prevalence of Neurological Disorders to Provide Market Opportunities in Future
There is an increasing prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and epilepsy, mainly in low- and middle-income countries. According to WHO, in 2024, about 50 million people worldwide are suffering from epilepsy, and about 80% of these people live in low- and middle-income countries. According to Parkinson’s Foundation, nearly 1 million people in the US had Parkinson’s disease in 2023, and the cases of the disease are expected to rise to 1.2 million by 2030.As per the same source, in 2023, more than 10 million people across the world were suffering from Parkinson’s disease. According to Alzheimer's Association, about 6.9 million people aged 65 years and above in America are expected to suffer from Alzheimer’s in 2024. Drugs are generally used for the treatment of these diseases. However, there is an increase in focus on the use of surgical methods such as deep brain stimulation for the treatment of neurological disorders, specifically when the drugs have low effects. According to an article "Epilepsy Surgery", epilepsy patients may be treated with the help of a small electrode.
As per the same article, about 50% of patients who undergo neuromodulation surgeries may experience better control of their seizures. Between 50% and 85% of individuals who undergo resection surgery or a hemispherectomy may experience significant improvement in seizure control and become seizure-free in some cases. Due to the better results of surgical procedures for neurological disorders, there will be an increase in the number of patients that will opt for these options, which, in turn, will fuel the number of neurological surgeries. As these surgeries are related to the brain, stabilization of the skull during the surgery is important. Thus, there will be an increase in demand for skull clamps. Thus, the increasing prevalence of neurological disorders is expected to offer lucrative opportunities for the growth of the skull clamp market during the forecast period.
Product -Based Insights
The skull clamp market, in terms of product, is segmented into three-pin skull clamp, four-pin skull clamp, and two-pin skull clamp. The three-pin skull clamp segment held the largest market share in 2023.Application -Based Insights
Based on application, the global skull clamp market is divided into surgery and medical imaging. The surgery segment held a larger share in the skull clamp market in 2023.Material -Based Insights
Based on material, the global skull clamp market is segmented into stainless steel, aluminum alloy, titanium, and radiolucent. In 2023, the stainless steel segment is likely to hold the largest share of the market.Accessories -Based Insights
Based on accessories, the global skull clamp market is segmented into skull pins, headrest, and others. In 2023, the skull pins segment is likely to hold the largest share of the market.End User -Based Insights
Based on end user, the skull clamp market is divided into hospitals, specialty clinics, and ambulatory surgical centers. In 2023, the hospitals segment is likely to hold the largest share of the market.Skull Clamp Market: Competitive Landscape and Key Developments
Black Forest Medical Group, Integra LifeSciences Holdings Corp, TeDan Surgical Innovations, Barrfab Industria Commerce Import and Export of Hospital Equipment Ltda, Herbert Thailand Co Ltd, Medifa GmbH & Co KG, Micromar Industria e Com Ltda, Schaerer Medical AG, Becton Dickinson and Co, and Baxter International Inc are among the key companies operating in the skull clamp market.The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), North American Spine Society are among the primary and secondary sources referred to while preparing the skull clamp market report.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the skull clamp market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the skull clamp market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the skull clamp market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Skull Clamp Market Landscape
5. Skull Clamp Market - Key Market Dynamics
6. Skull Clamp Market - Global Market Analysis
7. Skull Clamp Market Analysis - by Product
8. Skull Clamp Market Analysis - by Application
9. Skull Clamp Market Analysis - by Material
10. Skull Clamp Market Analysis - by Accessories
11. Skull Clamp Market Analysis - by End User
12. Skull Clamp Market - Geographical Analysis
13. Industry Landscape
14. Company Profiles
15. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Industrial Explosives Market
- Orica Ltd
- AECI Ltd
- Austin Powder Company
- Dyno Nobel Ltd
- Enaex SA
- MaxamCorp Holding SL
- Solar Industries India Ltd
- EPC Groupe
- Keltech Energies Ltd
- Hanwha Corp
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 174 |
| Published | August 2024 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value in 2023 | 2097.15 Million |
| Forecasted Market Value by 2031 | 4337.31 Million |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
